Expedia Group Inc vs Teladoc Health Inc — how do they compare? Expedia Group Inc trades at $274.22 (market cap $32.42B), while Teladoc Health Inc trades at $5.77 (market cap $1.01B). The key difference: Expedia Group Inc is far larger — about 32.1× Teladoc Health Inc's market cap, and Expedia Group Inc pays a 0.71% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Expedia Group Inc for 47 Days and Teladoc Health Inc for 39 Days on average.
| EXPE | TDOC | |
|---|---|---|
Market Cap | $32.42B | $1.01B |
Volume | 1,940,671 | 4,668,477 |
Sector | Consumer Cyclical | Health |
52-Week High | $339.13 | $9.72 |
52-Week Low | $188.51 | $4.47 |
Typical Hold Time | 47 Days | 39 Days |
Enterprise Value | $30.98B | $1.27B |
Dividend Yield | 0.71% | — |
Signals from Pluang's Aura AI — not financial advice
Expedia Group (EXPE) trades at $270.13, up 4.35% today, with a bullish technical signal and strong fundamental performance. The stock has consistently beaten earnings estimates in recent quarters, with Q2 2026 EPS of $5.76 surpassing the $5.22 forecast. Revenue growth is steady, reaching $14.73 billion in 2025, and the company maintains a high gross profit margin of 90.43%. However, recent news highlights competitive threats from AI agents, and the stock faces resistance near $275.
The outlook for EXPE is mixed; solid earnings growth and a consensus price target of $335.06 suggest upside potential, but investor sentiment is cautious due to AI disruption risks and a nearly even split between buy and hold ratings. Key risks include Meta's Muse AI agent potentially bypassing travel aggregators and ongoing layoffs impacting operational efficiency.
TDOC trades at $5.54, down 0.36% on the day, with a bearish technical signal and mixed earnings history. The company reported revenue of $2.53B in 2025 but a net loss of $200.32M, reflecting ongoing profitability challenges. Analyst consensus is a 'Hold' with a $8.83 price target, indicating potential upside. Recent news includes a CFO transition and legal investigations, adding to investor uncertainty.
The outlook remains cautious due to persistent losses and competitive pressures, though valuation metrics like P/S of 0.4 and EV/EBITDA of 5.89 suggest the stock is undervalued. Key risks include weak cash flow trends and BetterHelp segment volatility. Upside depends on execution in integrated care and cost management.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Expedia is the world's largest online travel agency by bookings, offering services for lodging (75% of total 2021 sales), air tickets (3%), rental cars, cruises, in-destination, and other (15%), and advertising revenue (7%). Expedia operates a number of branded travel booking sites, including Expedia.com, Hotels.com, Travelocity, Orbitz, Wotif, AirAsia, and Vrbo. It has also expanded into travel media with the acquisition of Trivago. Transaction fees for online bookings account for the bulk of sales and profits.
Read more on EXPE →Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →